Survey of a representative sample of patients after topicala) capsaicin 8% therapyb) lidocaine 5% therapyc) botulinum toxin A injectio
- Conditions
- Patients treated with at least one of the capsaicin, lidocaine or botulinum toxin at least once
- Registration Number
- DRKS00011877
- Lead Sponsor
- Berufgenossenschaftliches Universitätsklinikum Bergmannsheil gGmbH, Abteilung für Schmerzmedizin
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 224
Inclusion Criteria
All patients who a) received at least one treatment with the topical capsaicin 8% (Qutenza ®) in the own clinic since 2010 b) since 2008 received at least one Versatis® therapy in the own clinic c) since 2014 received at least one Botox® injection in the own clinic
Exclusion Criteria
lack of ability to provide information, cognitive limitations
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method overview of the frequency / reasons for a possible discontinuation of therapy or the frequency / reasons for further treatment
- Secondary Outcome Measures
Name Time Method Assessment of effectiveness (global impression)